{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:35:54Z","timestamp":1791722154945,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Institute of Eminence, Banaras Hindu University","award":["SRICC\/Bridge Grant\/2023-24\/8135"],"award-info":[{"award-number":["SRICC\/Bridge Grant\/2023-24\/8135"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93215-x","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:16:55Z","timestamp":1741853815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adropin ameliorates reproductive dysfunctions in letrozole-induced PCOS mouse"],"prefix":"10.1038","volume":"15","author":[{"given":"Shweta","family":"Maurya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taruna","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1849-3918","authenticated-orcid":false,"given":"Ajit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"93215_CR1","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232)","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I. & Yarali, H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. (Oxf. 27, 3067\u20133073. https:\/\/doi.org\/10.1093\/humrep\/des232) (2012).","journal-title":"Hum. Reprod. (Oxf"},{"key":"93215_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24)","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale, H. F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14, 270\u2013284. https:\/\/doi.org\/10.1038\/nrendo.2018.24) (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"93215_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic, D. A. et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr. Rev. 36, 487\u2013525 (2015). (DOI 10.1210\/er.2015\u2009\u2013\u20091018).","journal-title":"Endocr. Rev."},{"key":"93215_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/imj.12495)","volume":"44","author":"S Shorakae","year":"2014","unstructured":"Shorakae, S., Boyle, J. & Teede, H. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about. Int. Med. J. 44, 720\u2013726. https:\/\/doi.org\/10.1111\/imj.12495) (2014).","journal-title":"Int. Med. J."},{"key":"93215_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003)","volume":"26","author":"LJ Moran","year":"2015","unstructured":"Moran, L. J., Norman, R. J. & Teede, H. J. Metabolic risk in PCOS: phenotype and adiposity impact. Trends Endocrinol. Metab. 26, 136\u2013143. https:\/\/doi.org\/10.1016\/j.tem.2014.12.003) (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"93215_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098)","volume":"19","author":"ESHRE\/ASRM","year":"2004","unstructured":"ESHRE\/ASRM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41\u201347. https:\/\/doi.org\/10.1093\/humrep\/deh098) (2004).","journal-title":"Hum. Reprod."},{"key":"93215_CR7","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1210\/jcem.84.4.5596)","volume":"84","author":"MM Huber-Buchholz","year":"1999","unstructured":"Huber-Buchholz, M. M., Carey, D. G. & Norman, R. J. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J. Clin. Endocrinol. Metab. 84, 1470\u20131474. https:\/\/doi.org\/10.1210\/jcem.84.4.5596) (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"93215_CR8","doi-asserted-by":"publisher","unstructured":"Rababa\u2019h, A. M., Matani, B. R. & Yehya, A. An update of polycystic ovary syndrome: causes and therapeutics options. Heliyon 8, e11010. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11010) (2022 October 10).","DOI":"10.1016\/j.heliyon.2022.e11010)"},{"key":"93215_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","volume":"43","author":"EM Velazquez","year":"1994","unstructured":"Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F. & Glueck, C. J. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43, 647\u2013654 (1994). (DOI 10.1016\/0026\u20130495(94)90209-7).","journal-title":"Metabolism"},{"key":"93215_CR10","doi-asserted-by":"publisher","unstructured":"Glueck, C. J., Wang, P., Fontaine, R., Tracy, T. & Sieve-Smith, L. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS)11The full text of this article is available via JAH Online at http:\/\/www.elsevier.com\/locate\/jahonline. J. Adolesc. Health 29, 160\u2013169 (2001). https:\/\/doi.org\/10.1016\/S1054-139X(01)00202-6).","DOI":"10.1016\/S1054-139X(01)00202-6"},{"key":"93215_CR11","doi-asserted-by":"publisher","first-page":"CD003053","DOI":"10.1002\/14651858.CD003053.pub5)","volume":"5","author":"T Tang","year":"2012","unstructured":"Tang, T., Lord, J. M., Norman, R. J., Yasmin, E. & Balen, A. H. Insulin-sensitising drugs (metformin, Rosiglitazone, Pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst. Rev. 5, CD003053. https:\/\/doi.org\/10.1002\/14651858.CD003053.pub5) (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"93215_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/humupd\/dmp006)","volume":"15","author":"KA Toulis","year":"2009","unstructured":"Toulis, K. A. et al. Adiponectin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis. Hum. Reprod. Update. 15, 297\u2013307. https:\/\/doi.org\/10.1093\/humupd\/dmp006) (2009).","journal-title":"Hum. Reprod. Update"},{"key":"93215_CR13","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1210\/jc.2004-2152","volume":"90","author":"I Munir","year":"2005","unstructured":"Munir, I. et al. Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90, 4852\u20134857 (2005). (DOI 10.1210\/jc.2004\u20132152).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"93215_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09513590.2018.1534096)","volume":"35","author":"DP Baldani","year":"2019","unstructured":"Baldani, D. P. et al. Altered leptin, adiponectin, resistin and Ghrelin secretion May represent an intrinsic polycystic ovary syndrome abnormality. Gynecol. Endocrinol. 35, 401\u2013405. https:\/\/doi.org\/10.1080\/09513590.2018.1534096) (2019).","journal-title":"Gynecol. Endocrinol."},{"key":"93215_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.fertnstert.2006.11.120)","volume":"88","author":"TF Chan","year":"2007","unstructured":"Chan, T. F. et al. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil. Steril. 88, 401\u2013405. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.11.120) (2007).","journal-title":"Fertil. Steril."},{"key":"93215_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ejim.2007.05.014)","volume":"19","author":"D Panidis","year":"2008","unstructured":"Panidis, D. et al. Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur. J. Intern. Med. 19, 406\u2013412. https:\/\/doi.org\/10.1016\/j.ejim.2007.05.014) (2008).","journal-title":"Eur. J. Intern. Med."},{"key":"93215_CR17","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.2337\/db10-0124)","volume":"59","author":"BK Tan","year":"2010","unstructured":"Tan, B. K. et al. Metformin treatment May increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 59, 3023\u20133031. https:\/\/doi.org\/10.2337\/db10-0124) (2010).","journal-title":"Diabetes"},{"key":"93215_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/cen.12381)","volume":"81","author":"B Orlik","year":"2014","unstructured":"Orlik, B. et al. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf). 81, 529\u2013535. https:\/\/doi.org\/10.1111\/cen.12381) (2014).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"93215_CR19","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.2337\/db08-1528)","volume":"58","author":"BK Tan","year":"2009","unstructured":"Tan, B. K. et al. Insulin and Metformin regulate Circulating and adipose tissue chemerin. Diabetes 58, 1971\u20131977. https:\/\/doi.org\/10.2337\/db08-1528) (2009).","journal-title":"Diabetes"},{"key":"93215_CR20","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1210\/jc.2008-1833","volume":"94","author":"K Bozaoglu","year":"2009","unstructured":"Bozaoglu, K. et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J. Clin. Endocrinol. Metab. 94, 3085\u20133088 (2009). (DOI 10.1210\/jc.2008\u2009\u2013\u20091833).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"93215_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1095\/biolreprod.116.141754)","volume":"95","author":"J Roche","year":"2016","unstructured":"Roche, J. et al. Apelin (APLN) and Apelin receptor (APLNR) in human ovary: expression, signaling, and regulation of steroidogenesis in primary human luteinized granulosa cells. Biol. Reprod. 95, 104. https:\/\/doi.org\/10.1095\/biolreprod.116.141754) (2016).","journal-title":"Biol. Reprod."},{"key":"93215_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cmet.2008.10.011)","volume":"8","author":"KG Kumar","year":"2008","unstructured":"Kumar, K. G. et al. Identification of Adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell. Metab. 8, 468\u2013481. https:\/\/doi.org\/10.1016\/j.cmet.2008.10.011) (2008).","journal-title":"Cell. Metab."},{"key":"93215_CR23","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/oby.2012.31)","volume":"20","author":"KG Ganesh-Kumar","year":"2012","unstructured":"Ganesh-Kumar, K. G. et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity 20, 1394\u20131402. https:\/\/doi.org\/10.1038\/oby.2012.31) (2012).","journal-title":"Obesity"},{"key":"93215_CR24","doi-asserted-by":"publisher","unstructured":"Gao, S. et al. Therapeutic effects of Adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol. Metab. 4, 310\u2013324. https:\/\/doi.org\/10.1016\/j.molmet.2015.01.005) (2015 April 1).","DOI":"10.1016\/j.molmet.2015.01.005)"},{"key":"93215_CR25","doi-asserted-by":"publisher","first-page":"e14043","DOI":"10.14814\/phy2.14043)","volume":"7","author":"D Thapa","year":"2019","unstructured":"Thapa, D. et al. Adropin reduces blood glucose levels in mice by limiting hepatic glucose production. Physiol. Rep. 7, e14043. https:\/\/doi.org\/10.14814\/phy2.14043) (2019).","journal-title":"Physiol. Rep."},{"key":"93215_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.metabol.2019.06.005)","volume":"98","author":"TR Altamimi","year":"2019","unstructured":"Altamimi, T. R. et al. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency. Metabolism 98, 37\u201348. https:\/\/doi.org\/10.1016\/j.metabol.2019.06.005) (2019).","journal-title":"Metabolism"},{"key":"93215_CR27","doi-asserted-by":"publisher","first-page":"110532","DOI":"10.1016\/j.mce.2019.110532)","volume":"496","author":"M Jasaszwili","year":"2019","unstructured":"Jasaszwili, M. et al. Effects of Adropin on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes. Mol. Cell. Endocrinol. 496, 110532. https:\/\/doi.org\/10.1016\/j.mce.2019.110532) (2019).","journal-title":"Mol. Cell. Endocrinol."},{"key":"93215_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jez.2763)","volume":"341","author":"S Tripathi","year":"2024","unstructured":"Tripathi, S., Maurya, S. & Singh, A. Adropin May promote insulin stimulated steroidogenesis and spermatogenesis in adult mice testes. J. Exp. Zool. Pt A. 341, 86\u201398. https:\/\/doi.org\/10.1002\/jez.2763) (2024).","journal-title":"J. Exp. Zool. Pt A"},{"key":"93215_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00441-023-03852-9)","volume":"395","author":"S Tripathi","year":"2024","unstructured":"Tripathi, S., Maurya, S. & Singh, A. Adropin, a novel hepatokine: localization and expression during postnatal development and its impact on testicular functions of pre-pubertal mice. Cell. Tissue Res. 395, 171\u2013187. https:\/\/doi.org\/10.1007\/s00441-023-03852-9) (2024).","journal-title":"Cell. Tissue Res."},{"key":"93215_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12020-024-03921-1)","volume":"86","author":"S Tripathi","year":"2024","unstructured":"Tripathi, S., Maurya, S. & Singh, A. Adropin promotes testicular functions by modulating redox homeostasis in adult mouse. Endocrine 86, 428\u2013440. https:\/\/doi.org\/10.1007\/s12020-024-03921-1) (2024).","journal-title":"Endocrine"},{"key":"93215_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s42000-023-00476-0)","volume":"22","author":"S Maurya","year":"2023","unstructured":"Maurya, S., Tripathi, S., Arora, T. & Singh, A. Adropin May regulate corpus luteum formation and its function in adult mouse ovary. Hormones 22, 725\u2013739. https:\/\/doi.org\/10.1007\/s42000-023-00476-0) (2023).","journal-title":"Hormones"},{"key":"93215_CR32","doi-asserted-by":"publisher","first-page":"106404","DOI":"10.1016\/j.jsbmb.2023.106404)","volume":"234","author":"S Maurya","year":"2023","unstructured":"Maurya, S., Tripathi, S. & Singh, A. Ontogeny of Adropin and its receptor expression during postnatal development and its pro-gonadal role in the ovary of pre-pubertal mouse. J. Steroid Biochem. Mol. Biol. 234, 106404. https:\/\/doi.org\/10.1016\/j.jsbmb.2023.106404) (2023).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"93215_CR33","doi-asserted-by":"publisher","first-page":"106524","DOI":"10.1016\/j.jsbmb.2024.106524)","volume":"242","author":"S Maurya","year":"2024","unstructured":"Maurya, S., Tripathi, S., Arora, T. & Singh, A. Adropin May regulate ovarian functions by improving antioxidant potential in adult mouse. J. Steroid Biochem. Mol. Biol. 242, 106524. https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106524) (2024).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"93215_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/09513590.2017.1379498)","volume":"34","author":"A Bousmpoula","year":"2018","unstructured":"Bousmpoula, A. et al. Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles. Gynecol. Endocrinol. 34, 153\u2013156. https:\/\/doi.org\/10.1080\/09513590.2017.1379498) (2018).","journal-title":"Gynecol. Endocrinol."},{"key":"93215_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s40618-016-0453-5)","volume":"39","author":"T Kume","year":"2016","unstructured":"Kume, T. et al. A possible connection between tumor necrosis factor alpha and Adropin levels in polycystic ovary syndrome. J. Endocrinol. Investig. 39, 747\u2013754. https:\/\/doi.org\/10.1007\/s40618-016-0453-5) (2016).","journal-title":"J. Endocrinol. Investig"},{"issue":"36","key":"93215_CR36","doi-asserted-by":"publisher","first-page":"13366","DOI":"10.1074\/jbc.RA119.008967)","volume":"294","author":"S Gao","year":"2019","unstructured":"Gao, S. et al. The peptide hormone Adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity. J. Biol. Chem. 294 (36), 13366\u201313377. https:\/\/doi.org\/10.1074\/jbc.RA119.008967) (2019).","journal-title":"J. Biol. Chem."},{"key":"93215_CR37","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001)","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido, M. A. & Tena-Sempere, M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol. Metab. 35, 100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001) (2020).","journal-title":"Mol. Metab."},{"key":"93215_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035)","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz, R. et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456\u2013488. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.035) (2009).","journal-title":"Fertil. Steril."},{"key":"93215_CR39","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138)","volume":"93","author":"A Huang","year":"2010","unstructured":"Huang, A., Brennan, K. & Azziz, R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National institutes of health 1990 criteria. Fertil. Steril. 93, 1938\u20131941. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.12.138) (2010).","journal-title":"Fertil. Steril."},{"key":"93215_CR40","doi-asserted-by":"crossref","unstructured":"Nakamura, Y. et al. Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J. Clin. Endocrinol. Metab. 94, 2192\u20132198 (2009 June) (DOI 10.1210\/jc.2008\u20132374).","DOI":"10.1210\/jc.2008-2374"},{"key":"93215_CR41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/molehr\/gap082)","volume":"15","author":"J Kim","year":"2009","unstructured":"Kim, J., Bagchi, I. C. & Bagchi, M. K. Control of ovulation in mice by progesterone receptor-regulated gene networks. Mol. Hum. Reprod. 15, 821\u2013828. https:\/\/doi.org\/10.1093\/molehr\/gap082) (2009).","journal-title":"Mol. Hum. Reprod."},{"key":"93215_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tem.2007.08.001)","volume":"18","author":"HJ Teede","year":"2007","unstructured":"Teede, H. J., Hutchison, S. K. & Zoungas, S. The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol. Metab. 18, 273\u2013279. https:\/\/doi.org\/10.1016\/j.tem.2007.08.001) (2007).","journal-title":"Trends Endocrinol. Metab."},{"key":"93215_CR43","doi-asserted-by":"crossref","unstructured":"Rice, S., Pellatt, L., Ramanathan, K., Whitehead, S. A. & Mason, H. D. October 1. Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway. Endocrinology 150, 4794\u20134801 (DOI 10.1210\/en.2009\u2009\u2013\u20090540) (2009).","DOI":"10.1210\/en.2009-0540"},{"key":"93215_CR44","doi-asserted-by":"crossref","unstructured":"Shah, M. Z. & Shrivastava, V. K. Ameliorative effects of Quercetin on endocrine and metabolic abnormalities associated with experimentally induced polycystic ovary syndrome in mice. Comp. Clin. Pathol. 32(3), 383\u2013391 (2023 Jun).","DOI":"10.1007\/s00580-023-03446-5"},{"key":"93215_CR45","doi-asserted-by":"crossref","unstructured":"ul haq Shah, M. Z., Shrivastava, V. K., Mir, M. A. & Olaniyi, K. S. Role of diacerein on steroidogenesis and folliculogenesis related genes in ovary of letrozole-induced PCOS mice. Chemico-Biol. Interact. 25, 377(110468) (2023 May).","DOI":"10.1016\/j.cbi.2023.110468"},{"key":"93215_CR46","doi-asserted-by":"crossref","unstructured":"Shah, M. Z. et al. Effect of Quercetin on steroidogenesis and folliculogenesis in ovary of mice with experimentally-induced polycystic ovarian syndrome. Front. Endocrinol. 24, 14(1153289) (2023 Apr).","DOI":"10.3389\/fendo.2023.1153289"},{"key":"93215_CR47","doi-asserted-by":"crossref","unstructured":"ul haq Shah, M. Z., Shrivastava, V. K., Muzamil, S. & Olaniyi, K. S. Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1\/PON 1. BMC Endocr. Disorders 10, 24 (109) (2024 Jul).","DOI":"10.1186\/s12902-024-01639-9"},{"key":"93215_CR48","doi-asserted-by":"crossref","unstructured":"Shah, M. Z. et al. Chlorogenic acid restores ovarian functions in mice with letrozole-induced polycystic ovarian syndrome via modulation of adiponectin receptor. Biomedicines 14, 11(3):900 (2023 Mar).","DOI":"10.3390\/biomedicines11030900"},{"key":"93215_CR49","doi-asserted-by":"crossref","unstructured":"ul haq Shah, M. Z., Shrivastava, V. & Mir, M. A. Metformin treatment ameliorates endocrine-metabolic disturbances in letrozole-induced PCOS mice model by modulating adiponectin status. Obes. Med. 1, 31:100392 (2022 May).","DOI":"10.1016\/j.obmed.2022.100392"},{"key":"93215_CR50","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.1210\/jc.2004-0689","volume":"89","author":"S Palomba","year":"2004","unstructured":"Palomba, S. et al. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J. Clin. Endocrinol. Metab. 89, 4801\u20134809 (2004). (DOI 10.1210\/jc.2004\u2009\u2013\u20090689).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"93215_CR51","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/15548627.2021.1938914)","volume":"17","author":"S Kumariya","year":"2021","unstructured":"Kumariya, S., Ubba, V., Jha, R. K. & Gayen, J. R. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy 17, 2706\u20132733. https:\/\/doi.org\/10.1080\/15548627.2021.1938914) (2021).","journal-title":"Autophagy"},{"key":"93215_CR52","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/09513590.2018.1540567)","volume":"35","author":"X Li","year":"2019","unstructured":"Li, X. et al. The role of androgen in autophagy of granulosa cells from PCOS. Gynecol. Endocrinol. 35, 669\u2013672. https:\/\/doi.org\/10.1080\/09513590.2018.1540567) (2019).","journal-title":"Gynecol. Endocrinol."},{"key":"93215_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.repbio.2015.12.005)","volume":"16","author":"V Pandey","year":"2016","unstructured":"Pandey, V. et al. Role of oxidative stress and low-grade inflammation in letrozole-induced polycystic ovary syndrome in the rat. Reprod. Biol. 16, 70\u201377. https:\/\/doi.org\/10.1016\/j.repbio.2015.12.005) (2016).","journal-title":"Reprod. Biol."},{"key":"93215_CR54","first-page":"304","volume":"11","author":"PJ Parikha, Singh","year":"2019","unstructured":"Parikha, Singh, P. J. & Krishna, A. Anti-hyperglycaemic activity of Tribulus terrestris fruit extract restores metabolic imbalance in letrozole induced -PCOS mice. J. Pharmacogn Phytochem. 11, 304\u2013311 (2019).","journal-title":"J. Pharmacogn Phytochem"},{"key":"93215_CR55","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.2337\/db14-0388)","volume":"63","author":"S Gao","year":"2014","unstructured":"Gao, S. et al. Regulation of substrate oxidation preferences in muscle by the peptide hormone Adropin. Diabetes 63, 3242\u20133252. https:\/\/doi.org\/10.2337\/db14-0388) (2014).","journal-title":"Diabetes"},{"key":"93215_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/molehr\/gal057)","volume":"12","author":"E Elia","year":"2006","unstructured":"Elia, E., Sander, V. & Luchetti, C. G. The mechanisms involved in the action of Metformin in regulating ovarian function in hyperandrogenized mice. Mol. Hum. Reprod. 12, 475\u2013481. https:\/\/doi.org\/10.1093\/molehr\/gal057) (2006).","journal-title":"Mol. Hum. Reprod."},{"key":"93215_CR57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999)","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254. https:\/\/doi.org\/10.1006\/abio.1976.9999) (1976).","journal-title":"Anal. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93215-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93215-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:17:04Z","timestamp":1741853824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93215-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93215"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93215-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8659"}}